Clinical Trial Update: An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate) [Phase 1]

View source ↗

Summary

This Phase 1 open-label, randomized 3-period crossover trial evaluated the pharmacokinetics of sumatriptan when administered as TREXIMA (sumatriptan succinate /…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Imitrex (Sumatriptan)
• Trexima (sumatriptan/naproxen)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Phase 1 | Status: COMPLETED